Novel interfaces with the peripheral nervous system help neuroscientists explore new ways to treat injury and disease.
Novel interfaces with the peripheral nervous system help neuroscientists explore new ways to treat injury and disease.
Immune cells convert an immunosuppressive lipid into an anticancer immunity enhancer.
NCI trial leads to first drug approval for a very rare cancer.
March 2024. Full story at National Cancer Institute.
An immune signal that reprograms fat metabolism could help control nonalcoholic fatty liver disease.
Studies identify a marker of treatment response for patients with advanced, drug-resistant ovarian cancer.
Full story at National Cancer Institute.
Studying osteosarcoma in dogs may improve treatment options for people and pets.
A new view of cell division changes scientists’ thinking about how some cancer drugs impact cells.
Mental models recreate external events to track the passage of time.
Researchers zero in on an attention-generating part of the brain.
January 2024. Full story at MIT’s McGovern Institute.